Scalper1 News
December is usually a quiet month for medical tech news, but this year will bring a few potentially stock-moving events worth keeping an eye on. As you digest your Thanksgiving turkey, here are the top five in chronological order: By Dec. 5, biotech Incyte (INCY) is looking to get an important expansion of the label on its sole marketed drug, Jakafi. As explained in the recent Incyte profile in The New America, Incyte and its partner Novartis Scalper1 News
Scalper1 News